Skip to content
2000
Volume 5, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882

Abstract

Background

The global impact of COVID-19 resulted in widespread illness and death. The rapid evolution of SARS-CoV-2, accompanied by increased transmission caused by Variants of Concern (VOC), became a significant concern in the post-pandemic.

Objectives

This study has been conducted to evaluate the performance of multiplexed real-time reverse transcription-PCR (RT-PCR) assays for COVID-19 detection and the use of specific mutation RT-PCR-based approach to identify VOC in SARS-CoV-2 positive samples in the northern part of the UAE.

Methods

We selected 200 respiratory specimens tested between October 2022 to January 2023, at the Pure Lab, COVID Screening Lab, Al Qassimi Women's and Children's Hospital, Sharjah, UAE. We evaluated the performance of four commercially available RT-PCR kits for COVID-19 detection. Further, the positive samples were used to identify variants by variant detection kit as required for mutations in Spike protein (HV 69-70 DEL, N501Y, E484K, K417N) to identify Omicron, British and SARS-CoV-2 wild type (WT) E Gene variants, respectively.

Results

In the post-pandemic period, 153/200 (76.5%) positivity was observed. There was a higher prevalence of COVID-19 among males, accounting for 52% of the cases, in comparison to females 48% aged between 20-40 years. Variant analysis showed that 50 samples were detected for the SARS-CoV-2 OMICRON variant (B.1.1.529), 4 samples were detected for the SARS-CoV-2 British variant (B.1.1.7), however, 99 samples were detected for SARS-CoV-2 wild type (WT) E gene with no mutation.

Conclusion

This study demonstrates the efficacy of a rapid and cost-effective RT-PCR assay designed to detect spike mutations to effectively contribute to public health response efforts. Additionally, by performance evaluation of PCR kits for COVID-19 detection with the Cycle Threshold (CT) values obtained from diagnostic PCR, we can gather valuable insights into the viral load of samples. This information helps us gauge the extent of transmission and assess the severity of the disease within the population.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0102506882268552230922112521
2024-01-01
2025-04-23
The full text of this item is not currently available.

References

  1. GorbalenyaA.E. BakerS.C. BaricR.S. de GrootR.J. DrostenC. GulyaevaA.A. HaagmansB.L. LauberC. LeontovichA.M. NeumanB.W. PenzarD. PerlmanS. PoonL.L.M. SamborskiyD.V. SidorovI.A. SolaI. ZiebuhrJ. The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2.Nat. Microbiol.20205453654410.1038/s41564‑020‑0695‑z32123347
    [Google Scholar]
  2. World Health Organization (WHO)WHO coronavirus (COVID-19) dashboard.2023Available From: https://covid19.who.int (accessed 13th March 2023).
  3. MousavizadehL. GhasemiS. Genotype and phenotype of COVID-19: Their roles in pathogenesis.J. Microbiol. Immunol. Infect.202154215916310.1016/j.jmii.2020.03.02232265180
    [Google Scholar]
  4. AltamimiA.M. ObeidD.A. AlaifanT.A. TahaM.T. AlhothaliM.T. AlzahraniF.A. AlbarragA.M. Assessment of 12 qualitative RT-PCR commercial kits for the detection of SARS-CoV-2.J. Med. Virol.20219353219322610.1002/jmv.2690033629747
    [Google Scholar]
  5. WHOWHO coronavirus (COVID-19) dashboard with vaccination data.Available From: https://covid19.who.int/
  6. SARS-CoV-2 sequences by variant.Available From: https://ourworldindata.org/grapher/covid-variants-bar? (Nov 7, 2022).2022
  7. CoVariants per country.https://covariants.org/per-country
  8. IslamO.K. Al-EmranH.M. HasanM.S. AnwarA. JahidM.I.K. HossainM.A. Emergence of european and north american mutant variants of SARS-CoV-2 in south-east asia.Transbound. Emerg. Dis.202168282483210.1111/tbed.1374832701194
    [Google Scholar]
  9. VenkatakrishnanA.J. AnandP. LenehanP.J. SuratekarR. RaghunathanB. NiesenM.J.M. SoundararajanV. On the origins of omicron’s unique spike gene insertion.Vaccines2022109150910.3390/vaccines1009150936146586
    [Google Scholar]
  10. HasanM.S. IslamM.T. AlamA.S.M.R.U. SarkarS.L. RahmanM.S. IslamO.K. SetuM.A.A. ChakrovartyT. Al-EmranH.M. JahidI.K. HossainM.A. Initial reports of the SARS-CoV -2 Delta variant (B.1.617.2 lineage) in Bangladeshi patients: Risks of cross-border transmission from India.Health Sci. Rep.202143e36610.1002/hsr2.36634522791
    [Google Scholar]
  11. Science brief: Emerging SARS-CoV-2 variants.Available From: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-emerging-variants.html 2019
  12. AlamA.S.M.R.U. IslamO.K. HasanM.S. IslamM.R. MahmudS. Al-EmranH.M. JahidI.K. CrandallK.A. HossainM.A. Dominant clade-featured SARS-CoV-2 co-occurring mutations reveal plausible epistasis: An in silico based hypothetical model.J. Med. Virol.20229431035104910.1002/jmv.2741634676891
    [Google Scholar]
  13. La RosaG. ManciniP. Bonanno FerraroG. VeneriC. IaconelliM. LucentiniL. BonadonnaL. BrusaferroS. BrandtnerD. FasanellaA. PaceL. ParisiA. GalanteD. SuffrediniE. Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein.Water Res.202119711710410.1016/j.watres.2021.11710433857895
    [Google Scholar]
  14. HongK.H. LeeS.W. KimT.S. HuhH.J. LeeJ. KimS.Y. ParkJ.S. KimG.J. SungH. RohK.H. KimJ.S. KimH.S. LeeS.T. SeongM.W. RyooN. LeeH. KwonK.C. YooC.K. Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea.Ann. Lab. Med.202040535136010.3343/alm.2020.40.5.35132237288
    [Google Scholar]
  15. CormanV.M. LandtO. KaiserM. MolenkampR. MeijerA. ChuD.K.W. BleickerT. BrüninkS. SchneiderJ. SchmidtM.L. MuldersD.G.J.C. HaagmansB.L. van der VeerB. van den BrinkS. WijsmanL. GoderskiG. RometteJ.L. EllisJ. ZambonM. PeirisM. GoossensH. ReuskenC. KoopmansM.P.G. DrostenC. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.Euro Surveill.2020253200004510.2807/1560‑7917.ES.2020.25.3.200004531992387
    [Google Scholar]
  16. ZhouY. PeiF. JiM. WangL. ZhaoH. LiH. YangW. WangQ. ZhaoQ. WangY. Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection kits and strategy to reduce false negative.PLoS One20201511e024146910.1371/journal.pone.024146933206690
    [Google Scholar]
  17. LuY. LiL. RenS. LiuX. ZhangL. LiW. YuH. Comparison of the diagnostic efficacy between two PCR test kits for SARS-CoV-2 nucleic acid detection.J. Clin. Lab. Anal.20203410e2355410.1002/jcla.2355432977349
    [Google Scholar]
  18. WHOLaboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance. 2 March 2020; (No. WHO/COVID-19/laboratory/2020.4).World Health Organization2020
    [Google Scholar]
  19. MahallawiW.H. AlsamiriA.D. DabbourA.F. AlsaeediH. Al-ZalabaniA.H. Association of viral load in SARS-CoV-2 patients with age and gender.Front. Med.202183960821510.3389/fmed.2021.60821533585523
    [Google Scholar]
  20. Ur RehmanM. Sajjad NaqviS. UllahR. ArshadN. AmmadM. Ul AinQ. RazzakA. YousafM. HussainA. HasanT.N. Elucidation of correlation between SARS-CoV-2 RdRp and N gene cycle threshold (Ct) by RT-PCR with age and gender.Clin. Chim. Acta2022533424710.1016/j.cca.2022.06.00835714938
    [Google Scholar]
  21. SaglikI. EnerB. AkalinH. OzdemirB. OcakogluG. YalcinB. OnalU. Aydin GuçluO. Acet OzturkN.A. TuzemenU. DemirdogenE. Gorek DilektasliA. AgcaH. KazakE. CoskunF. HeperY. PayasliogluM. EdigerD. UrsavasA. YilmazE. OzakinC. UzaslanE. KaradagM. Association of SARS-CoV-2 cycle threshold (Ct) values with clinical course and serum biomarkers in COVID-19 patients.J. Infect. Dev. Ctries.202216344545210.3855/jidc.1581835404849
    [Google Scholar]
  22. SadeghiF. PournajafA. HalajiM. ChehraziM. AmiriF.H. AmoliS.S. HasanzadehA. JavanianM. BayaniM. Haddad ZavarehM.S. ShokriM. BabazadehA. MohammadiM. MehdinezhadH. MonadiM. MalehP.A. NouriH.R. DaraeiA. PashaM.Y. TouraniM. AhmadianS.R. EsmailzadehN. MirtabarS.M. AsadiS. NasiraieE. EzamiN. GorjinejadS. FallhpourK. FakhraieF. BeheshtiY. BaghershiroodiM. RastiF. SalehiM. AleahmadA. BabapourR. MalekzadehR. KashiR.H. YahyapourY. A large retrospective study of epidemiological characteristics of COVID-19 patients in the north of Iran: Association between SARS-CoV-2 RT-PCR Ct values with demographic data.Int. J. Clin. Pract.202220221910.1155/2022/145570835685485
    [Google Scholar]
  23. DergaaI. AbubakerM. SouissiA. MohammedA.R. VarmaA. MusaS. Al NaamaA. MkaouerB. Ben SaadH. Age and clinical signs as predictors of COVID-19 symptoms and cycle threshold value.Libyan J. Med.2022171201033710.1080/19932820.2021.201033734895104
    [Google Scholar]
  24. ShahS. SinghalT. DavarN. ThakkarP. No correlation between Ct values and severity of disease or mortality in patients with COVID 19 disease.Indian J. Med. Microbiol.202139111611710.1016/j.ijmmb.2020.10.02133610241
    [Google Scholar]
  25. GuanW. NiZ. HuY. LiangW. OuC. HeJ. LiuL. ShanH. LeiC. HuiD.S.C. DuB. LiL. ZengG. YuenK.Y. ChenR. TangC. WangT. ChenP. XiangJ. LiS. WangJ. LiangZ. PengY. WeiL. LiuY. HuY. PengP. WangJ. LiuJ. ChenZ. LiG. ZhengZ. QiuS. LuoJ. YeC. ZhuS. ZhongN. China Medical Treatment Expert Group for Covid-19 Clinical characteristics of coronavirus disease 2019 in China.N. Engl. J. Med.2020382181708172010.1056/NEJMoa200203232109013
    [Google Scholar]
  26. RabaanA.A. TirupathiR. SuleA.A. AldaliJ. MutairA.A. AlhumaidS. Muzaheed GuptaN. KoritalaT. AdhikariR. BilalM. DhawanM. TiwariR. MitraS. EmranT.B. DhamaK. Viral dynamics and real-time RT-PCR Ct values correlation with disease severity in COVID-19.Diagnostics2021116109110.3390/diagnostics1106109134203738
    [Google Scholar]
  27. DipS.D. SarkarS.L. SetuM.A.A. DasP.K. PramanikM.H.A. AlamA.S.M.R.U. Al-EmranH.M. HossainM.A. JahidI.K. Evaluation of RT-PCR assays for detection of SARS-CoV-2 variants of concern.Sci. Rep.2023131234210.1038/s41598‑023‑28275‑y36759632
    [Google Scholar]
  28. BedottoM. FournierP.E. HouhamdiL. LevasseurA. DelerceJ. PinaultL. PadaneA. ChamiehA. Tissot-DupontH. BrouquiP. SokhnaC. AzarE. SaileR. MboupS. BitamI. ColsonP. RaoultD. Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant.J. Clin. Virol.202113910481410481410.1016/j.jcv.2021.10481433836314
    [Google Scholar]
  29. HamillV NollL LuN Molecular detection of SARS-CoV-2 strains and differentiation of delta variant strains.Transbound. Emerg. Dis.2021202110.1111/tbed.1444334964565
    [Google Scholar]
  30. GarsonJ.A. BadruS. ParkerE. TedderR.S. McClureM.O. Highly sensitive and specific detection of the SARS-CoV-2 Delta variant by double-mismatch allele-specific real time reverse transcription PCR.J. Clin. Virol.202214610504910.1016/j.jcv.2021.10504934871906
    [Google Scholar]
  31. PetersonSW LidderR DaigleJ. RT-qPCR detection of SARS-CoV-2 mutations S 69-70 del, SN501Y and N D3L associated with variants of concern in canadian wastewater samples.Sci Total Environ2022810151283
    [Google Scholar]
  32. EsmanA. CherkashinaA. MironovK. DubodelovD. SalamaikinaS. GolubevaA. GasanovG. KhafizovK. PetrovaN. CherkashinE. AkimkinV. SARS-CoV-2 variants monitoring using real-time PCR.Diagnostics20221210238810.3390/diagnostics1210238836292077
    [Google Scholar]
  33. AlsafarH. AlbreikiM. MousaM. AzmanS.K. VuriviH. WaasiaF. RutaD. AlhosaniF. AlmazroueiS. AbuyadekR. SelvarajF. Chaves-CoiraI. ZvereffV. Abdel-MalekM.A.Y. AlkaabiN. UddinM. Al AwadhiT. Al MarzouqiN. Al AttarF. Al ShamsiS. Al ShehhiF. AlteneijiH. MohamedK. Al MuhairiN. AlRandH. FikriA. HenschelA. Genomic epidemiology and emergence of SARS-CoV-2 variants of concern in the United Arab Emirates.Sci. Rep.20221211466910.1038/s41598‑022‑16967‑w36038563
    [Google Scholar]
  34. HarveyW.T. CarabelliA.M. JacksonB. GuptaR.K. ThomsonE.C. HarrisonE.M. LuddenC. ReeveR. RambautA. PeacockS.J. RobertsonD.L. COVID-19 Genomics UK (COG-UK) Consortium SARS-CoV-2 variants, spike mutations and immune escape.Nat. Rev. Microbiol.202119740942410.1038/s41579‑021‑00573‑034075212
    [Google Scholar]
  35. StarrT.N. GreaneyA.J. HiltonS.K. EllisD. CrawfordK.H.D. DingensA.S. NavarroM.J. BowenJ.E. TortoriciM.A. WallsA.C. KingN.P. VeeslerD. BloomJ.D. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding.Cell2020182512951310.e2010.1016/j.cell.2020.08.01232841599
    [Google Scholar]
  36. DaviesN.G. KlepacP. LiuY. PremK. JitM. PearsonC.A.B. QuiltyB.J. KucharskiA.J. GibbsH. CliffordS. GimmaA. van ZandvoortK. MundayJ.D. DiamondC. EdmundsW.J. HoubenR.M.G.J. HellewellJ. RussellT.W. AbbottS. FunkS. BosseN.I. SunY.F. FlascheS. RoselloA. JarvisC.I. EggoR.M. CMMID COVID-19 working group Age-dependent effects in the transmission and control of COVID-19 epidemics.Nat. Med.20202681205121110.1038/s41591‑020‑0962‑932546824
    [Google Scholar]
  37. HoudaB. DiawaraI. SmyejI. Epidemiological description and analysis of RdRp, E and N genes dynamic by RT-PCR of SARS-CoV-2 in Moroccan population: Experience of the national reference laboratory (LNR)-UM6SSMedRxiv2020
    [Google Scholar]
  38. JiangC. ChenQ. XieM. Smoking increases the risk of infectious diseases: A narrative review.Tob. Induc. Dis.202018July6010.18332/tid/12384532765200
    [Google Scholar]
  39. KleinS.L. FlanaganK.L. Sex differences in immune responses.Nat. Rev. Immunol.2016161062663810.1038/nri.2016.9027546235
    [Google Scholar]
  40. Ghare NazM.S. BanaeiM. DashtiS. TehraniF.R. An overview of sex hormones in relation to SARS-CoV-2 infection.Future Virol.202116855556410.2217/fvl‑2021‑005834306167
    [Google Scholar]
  41. TalaB. DominikM. MarcoK. Post COVID-19 condition after wildtype, delta, and omicron variant SARS-CoV-2 infection and vaccination: pooled analysis of two population-based cohorts.medRxiv20222228033310.1101/2022.09.25.22280333
    [Google Scholar]
  42. AntonelliM. PujolJ.C. SpectorT.D. OurselinS. StevesC.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2.Lancet2022399103432263226410.1016/S0140‑6736(22)00941‑235717982
    [Google Scholar]
  43. MoriokaS. TsuzukiS. SuzukiM. TeradaM. AkashiM. OsanaiY. KugeC. SanadaM. TanakaK. MarukiT. TakahashiK. SaitoS. HayakawaK. TeruyaK. HojoM. OhmagariN. Post COVID-19 condition of the Omicron variant of SARS-CoV-2.J. Infect. Chemother.202228111546155110.1016/j.jiac.2022.08.00735963600
    [Google Scholar]
  44. Fernández-de-las-PeñasC Cancela-CillerueloI Rodríguez-JiménezJ. Associated-onset symptoms and post-COVID-19 symptoms in hospitalized COVID-19 survivors infected with wuhan, alpha or delta SARS-CoV-2 variant.Pathogens202211725
    [Google Scholar]
/content/journals/nemj/10.2174/0102506882268552230922112521
Loading
/content/journals/nemj/10.2174/0102506882268552230922112521
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): COVID-19; Ct values; RT-PCR; SARS-CoV-2; Variant analysis; Variant of Concern
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test